SARA AMBATT: Open Payments
NPI 1821384892 · MONSEY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,668 in 16 payments from 13 companies in 2025. Trend: 2023 $652 · 2024 $1,225 · 2025 $1,668
Food & beverage: $1,668
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $385 |
| Janssen Pharmaceuticals, Inc | 1 | $149 |
| Stryker Corporation | 1 | $143 |
| Agios Pharmaceuticals, Inc. | 1 | $130 |
| Boston Scientific Corporation | 1 | $130 |
| UCB, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Sage Therapeutics, LLC | 1 | $120 |
| Davol Inc. | 2 | $120 |
| Corcept Therapeutics | 1 | $78 |
Products named: COBENFY, INVEGA SUSTENNA, MAKO, PYRUKYND, WATCHMAN FLX, Nayzilam, TEZSPIRE, Phasix Mesh.
Industry payments across NY — which companies pay providers there.
